Navigation Links
Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds

st frequent pathogen among the difficult-to-treat invasive mould infections.

Poster P987 showed that isavuconazole is completely bioavailable, supporting early switch to the oral dosage form in the clinic. Some azoles can cause cardiac disturbances. Isavuconazole showed no QT prolongation in the study presented (P1675).

List of Ceftobiprole Presentations

P710 Baseline activity of ceftobiprole against methicillin-susceptible and -resistant staphylococcal clinical isolates from Europe collected in 2005-2006. T. Davies, D. Sahm, R. Flamm, K. Bush (Raritan, Herndon, U.S.)

P779 Pharmacokinetics of ceftobiprole following single and multiple intravenous infusions administered to healthy subjects. B. Murthy, D. Skee, D. Wexler, D. Balis, I. Chang, D. Desai-Kreiger, G. Noel (Raritan, U.S.)

P780 Activity of ceftobiprole tested against contemporary European Enterobacteriaceae and Pseudomonas aeruginosa (2005-2006). T. Fritsche, H. Sader, P. Strabala, R. Jones (North Liberty, U.S.)

P781 Activity of ceftobiprole tested against staphylococcal and streptococcal isolates recovered from patients in European medical centres (2005-2006). T. Fritsche, H. Sader, P. Strabala, R. Jones (North Liberty, U.S.)

P783 QT/QTc assessment of ceftobiprole in a single-dose study. D. Balis, R. Strauss, B. Murthy, H. Tiian, G. Noel (Raritan, U.S.)

P784 In vitro activity of ceftobiprole, dalbavancin and tigecycline against methicillin-resistant Staphylococcus aureus strains from hospitalised patients in Belgium. O. Denis, C. Nonhoff, A. Deplano, M. Hallin, R. De Ryck, S. Rottiers, S. Crevecoeur, M.J. Struelens (Brussels, BE)

P1321 Regional variation in Panton-Valentine leukocidin positivity among S. aureus isolates in complicated skin and skin structure infections. R. Strauss, K. Amsler, M. Jacobs, K. Bush, G. Noel (Raritan, U.S.)

P2024 Profile of ceftobiprole activity against S. aureus, S. pneumoniae, Enterobacteriaceae, and P. aeru
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
2. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
3. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
6. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
7. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
8. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
9. Inspire Announces Presentations at Two European Scientific Conferences
10. HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
11. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
Post Your Comments:
(Date:8/18/2008)...der with Strong Clinical Research Relationships an...ations to Lead Commercialization, SANTA CLARA, Ca... Inc.,(OTC Bulletin Board: NWCI) a cardiac diagno...ncent W. Renz has joined NewCardio as its presiden...zation effort, to include,business development, cl...
(Date:8/17/2008)...tralia, Aug. 17 /Xinhua-- P...that the first pivotal Phase 3,clinical trial of B...,completed enrolment., The first efficacy data fr...e first half of 2009. The trial commenced its dosi...tment target of 250 subjects in June,2008 and clos...
(Date:8/14/2008)...A Complimentary Continuing Education Activity, VO...rus (CMV) is a,significant cause of morbidity and ... transplantation. The clinical manifestations of C...inal disease to life-threatening,pneumonia, myelos...r to prevent CMV infection and reduce CMV drug res...
(Date:8/14/2008)...EACH, Fla., Aug. 14 /- The Clinical T...ed at educating physicians,clinical coordinators,...,clinical trial. It will be held in Boca Raton at ...investigators, clinical coordinators, monitors and... about how to incorporate,clinical trials into a p...
Breaking Medicine Technology:Vincent W. Renz Joins NewCardio as President 2Vincent W. Renz Joins NewCardio as President 3Vincent W. Renz Joins NewCardio as President 4Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings Inc Prompt Notice of Noncompliance from the Nasdaq Global Market 14205 1Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings Inc Prompt Notice of Noncompliance from the Nasdaq Global Market 14205 2WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 1WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 2WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 3WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 4WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 5WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 6WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 7WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 8WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 9WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 10WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 11WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 12Cardiac Science to Present at the Seventh Annual Invest Northwest Conference 14201 1Cardiac Science to Present at the Seventh Annual Invest Northwest Conference 14201 2deCODE Genetics Announces Full year 2007 Financial Results 3913 1deCODE Genetics Announces Full year 2007 Financial Results 3913 2deCODE Genetics Announces Full year 2007 Financial Results 3913 3deCODE Genetics Announces Full year 2007 Financial Results 3913 4deCODE Genetics Announces Full year 2007 Financial Results 3913 5deCODE Genetics Announces Full year 2007 Financial Results 3913 6deCODE Genetics Announces Full year 2007 Financial Results 3913 7deCODE Genetics Announces Full year 2007 Financial Results 3913 8deCODE Genetics Announces Full year 2007 Financial Results 3913 9
...rCare offers five questions to help women,learn ab...June 12, 2007 – According to a new,GfK Roper...national,nonprofit cancer support organization, wh...id they know at least a fair amount,about breast c...,progress made in treatment. Fewer than one out of...
..., June 13, 2007--Three new drugs for,rheumatoid ar...t,for this difficult and debilitating condition. T... published early Online and in an,upcoming edition...onic,inflammatory joint diseases, affecting 0&midd...sed world. Its typical symptoms are,joint pain, st...
Other Medicine Technology:Women Well-Informed About Breast Cancer, Yet Lacking Knowledge,About Current Treatments, New Survey Finds 2Women Well-Informed About Breast Cancer, Yet Lacking Knowledge,About Current Treatments, New Survey Finds 3Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment 2Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment 3
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...oped by scientists to enable the easy detection of...are two factors which are called for// where cance...archers led by Professor Calum McNeil are engaged ...er markers - proteins or other molecules produced ...
... statement, highlighting the unwillingness of Chin... bird flu outbreaks.// This was stated following a...ath, by Beijing. The deadly avian bird flu virus ...41-year-old factory worker, from the Southeastern ...
...ence of H5N1 bird flu strain in the poultry sample... the deadly bird flu strain // in six villages Mod... of Romania. Early this month five new cases of ... in Buzau County. Bird flu was first detected in D...
... at the UT Southwestern Medical Center has found t... urinary bladder if a woman is coached during labo... presence of a coach does not seem to provide any ...shortening labor. The study is the first of its k...
Other Medicine News:Health News:Coaching In Labor Could Increase Bladder Problems 2
...e is a synonym for pipetting accuracy, a smooth st...erating comfort. Its single, multifunctional butto...-out as well as eject the tip. Product features:Ep...cy and precision. Ejection sleeve can be removed t...
25L
...ue!, Comfortable feel and less hand fatigue with ...ile pipetting with smooth, light plunger spring ac...ation and sterilization without the need for recal...eproducible, accurate volume settings , Accepts u...
50L
Medicine Products: